Early Bactericidal Activity of Moxifloxacin in Treatment of Pulmonary Tuberculosis: a Prospective, Randomized Study
Author:
Affiliation:
1. Department of Chest and Infectious Diseases, City Hospital Emil von Behring/Chest Hospital Heckeshorn
2. Institute of Microbiology, City Hospital Emil von Behring, Freie Universität Berlin, 14195 Berlin, Germany
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.48.3.780-782.2004
Reference14 articles.
1. Crofton J. P. Chaulet and D. Maher. 1997. Guidelines for the managment of drug-resistant tuberculosis. World Health Organization Geneva Switzerland.
2. Gillespie, S. H., and O. Billington. 1999. Activity of moxifloxacin against mycobacteria. J. Antimicrob. Chemother.44:393-395.
3. Gillespie, S. H., R. D. Gosling, and B. M. Charalambous. 2002. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. Am. J. Respir. Crit. Care Med.166:31-35.
4. Hafner, R., J. A. Cohn, D. J. Wright, N. E. Dunlap, M. J. Egorin, M. E. Enama, K. Muth, C. A. Peloquin, N. Mor, L. B. Heifets, et al. 1997. Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. Am. J. Respir. Crit. Care Med.156:918-923.
5. Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs;European Respiratory Journal;2023-06-15
2. Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies;Expert Review of Anti-infective Therapy;2023-05-08
3. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs;2023-01-20
4. Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement;Frontiers in Cellular and Infection Microbiology;2022-09-29
5. Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species;Antimicrobial Agents and Chemotherapy;2022-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3